Anticancer potential of Viola cornuta-derived green-synthesized CuO nanoparticles via ROS-induced apoptosis in breast

Maryam Fekri Soufiabadi1, Mahsa Ziasistani1, Hannaneh Bazgir1

  • 1Pathology and Stem Cell Research Center, Kerman University of Medical Sciences, Kerman, Iran.

Cytotechnology
|July 26, 2026
PubMed

Insights

Green-synthesized copper oxide nanoparticles (CuO-NPs) show promise in targeting breast cancer cells. These nanoparticles effectively induce apoptosis in cancer cells while sparing normal cells, offering a potential new therapeutic avenue.

Area of Science:

  • Nanotechnology
  • Biomedical Engineering
  • Oncology

Background:

  • Breast cancer poses a significant global health challenge, with current treatments often hampered by drug resistance.
  • Novel therapeutic strategies are crucial to overcome treatment limitations and improve patient outcomes.

Purpose of the Study:

  • To evaluate the in vitro apoptotic effects of green-synthesized copper oxide nanoparticles (CuO-NPs) on human breast cancer cells (MCF7).
  • To compare the efficacy and selectivity of CuO-NPs against normal epithelial cells (MCF10A).

Main Methods:

  • Green synthesis of CuO-NPs using Viola corneta leaf extract.
  • Characterization of CuO-NPs using XRD, FTIR, and SEM.
  • In vitro assays including cell viability, ROS production, Annexin V/PI staining, cell cycle analysis, and gene expression profiling.

Main Results:

  • CuO-NPs demonstrated selective toxicity, with lower IC50 values for MCF7 cells (35.4 µg/mL) compared to MCF10A cells (85 µg/mL).
  • Treatment with CuO-NPs significantly increased reactive oxygen species (ROS) production and induced apoptosis in MCF7 cells.
  • Flow cytometry revealed an increase in the SubG1 phase, indicating cell cycle arrest, and real-time PCR showed altered expression of apoptosis-related genes.

Conclusions:

  • Green-synthesized CuO-NPs effectively induce apoptosis in breast cancer cells.
  • CuO-NPs exhibit selective cytotoxicity, targeting cancer cells while minimizing damage to normal cells.
  • These findings suggest CuO-NPs as a potential therapeutic agent for breast cancer treatment.

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...